New Neurological Findings and Documentation System Developed at Göttingen University

MEDNOVO Medical Software Solutions GmbHAn innovative neurological findings and documentation system named "NEMESYS" has been developed in the Department of Clinical Neurophysiology at Göttingen University School of Medicine. As regards content NEMESYS was developed in the Department of Clinical Neurophysiology at the University Hospital Göttingen (UKG) by Professor (Prof. Dr.) W. Paulus, Director of the Department of Clinical Neurophysiology, and private lecturer (Priv. Doz. Dr. med.) F. Tergau, St. Bernward Hospital in Hildesheim, formerly Department of Clinical Neurophysiology of the UKG. Technically NEMESYS was developed by Dipl. Phys. J. Lessing (Faculty of Physics).

From the left: Dipl.-Ing. Markus Mladek (MBM), Michael Heinlein (Managing Director  MEDNOVO Medical Software Solutions GmbH), Dr. Hans-Joachim Conrad (Executive Board of Management and Administration of the Göttingen University School of Medicine), Prof. Dr. Walter Paulus (Director of the Department of Clinical Neurophysiology)
From the left (Photo: umg): Dipl.-Ing. Markus Mladek (MBM), Michael Heinlein (Managing Director MEDNOVO Medical Software Solutions GmbH), Dr. Hans-Joachim Conrad (Executive Board of Management and Administration of the Göttingen University School of Medicine), Prof. Dr. Walter Paulus (Director of the Department of Clinical Neurophysiology).

MBM ScienceBridge GmbH, the technology transfer organization of Göttingen University, has been able to win the company MEDNOVO Medical software Solutions GmbH from Berlin as a licence partner for NEMESYS. "This partnership of science and economy again is a good example how our inhouse innovations are financially sensibly transformed into a marketable product for the single scientist and for Göttingen University", says Dr. Hans-Joachim Conrad, Executive Board of Management and Administration of the Göttingen University School of Medicine. The two partners have now signed a cooperation agreement.

NEMESYS is an absolute novelty in its function and its applicability in neurology: NEMESYS runs as a client-server-application on a database. By digital connection to neurological derivation devices (e.g. EEG, EMG), it is possible for the first time to work on different networked workplaces. Moreover, NEMESYS simplifies and standardizes the findings documentation in the area of Clinical Neurophysiology. The new system provides finding modules for the essential neurodiagnostical examination proceedings like EEG, EMG, EP, transcranial magnet stimulation, doppler-/ duplex sonography and EEG monitoring.

NEMESYS was certified by the German Society for Clinical Neurophysiology and Functional Imaging (DGKN). The extent of documentation as well as structure and classification of the findings modules were developed in arrangement with the DGKN and geared at international documentation standards.

Professor Walter Paulus, Director of the Department of Clinical Neurophysiology at the UKG: "We are pleased to have found an innovative partner like the company MEDNOVO, who will not only market but also enhance NEMESYS."

MEDNOVO offers the system NEMESYS as an additional module for its product family MediColor, an imaging and findings documentation system in functional diagnostics. Michael Heinlein, Managing Director of MEDNOVO Medical Software Solutions GmbH: "With the acquisition of NEMESYS we can complement the content of our system MediColor very well. In the near future, we will offer MediColor-Nemesys not only in Germany but also internationally."

NEMESYS is already in use at the University Hospital of the Georg-August-University Göttingen, at the Hospital Bremen-East, and at the Hospital of the Johannes-Gutenberg-University Mainz.

About the Department of Clinical Neurophysiology at Göttingen University
The main emphasis of the research at the Department of Clinical Neurophysiology at Göttingen University is focused on the field of epilepsy and Morbus Parkinson as well as on the further development of the methods documented in NEMESYS. Moreover, an English NEMESYS version shall carry this documentation standard also to the Anglo-Saxon countries. For further information, please visit www.neurologie.uni-goettingen.de

About MBM Science Bridge GmbH
The MBM Science Bridge GmbH is the technology transfer organization of the University and operates as a mediator between inventors and industry partners. For further information, please visit www.sciencebridge.de

About MEDNOVO Medical Software Solutions GmbH
The MEDNOVO Medical Software Solutions GmbH is specialized in the de-velopment of medical documentation systems and the connection and integration of medical devices with various hospital information systems (HIS). For further information, please visit www.mednovo.de

Most Popular Now

Most Advanced Artificial Touch for Brain…

For the first time ever, a complex sense of touch for individuals living with spinal cord injuries is a step closer to reality. A new study published in Science, paves...

Predicting the Progression of Autoimmune…

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies...

Major EU Project to Investigate Societal…

A new €3 million EU research project led by University College Dublin (UCD) Centre for Digital Policy will explore the benefits and risks of Artificial Intelligence (AI) from a societal...

Using AI to Uncover Hospital Patients�…

Across the United States, no hospital is the same. Equipment, staffing, technical capabilities, and patient populations can all differ. So, while the profiles developed for people with common conditions may...

New AI Tool Uses Routine Blood Tests to …

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors - a type of...

New Method Tracks the 'Learning Cur…

Introducing Annotatability - a powerful new framework to address a major challenge in biological research by examining how artificial neural networks learn to label genomic data. Genomic datasets often contain...

Picking the Right Doctor? AI could Help

Years ago, as she sat in waiting rooms, Maytal Saar-Tsechansky began to wonder how people chose a good doctor when they had no way of knowing a doctor's track record...

From Text to Structured Information Secu…

Artificial intelligence (AI) and above all large language models (LLMs), which also form the basis for ChatGPT, are increasingly in demand in hospitals. However, patient data must always be protected...

AI Innovation Unlocks Non-Surgical Way t…

Researchers have developed an artificial intelligence (AI) model to detect the spread of metastatic brain cancer using MRI scans, offering insights into patients’ cancer without aggressive surgery. The proof-of-concept study, co-led...

Deep Learning Model Helps Detect Lung Tu…

A new deep learning model shows promise in detecting and segmenting lung tumors, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA)...

One of the Largest Global Surveys of Soc…

As leaders gather for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm of Bayer, and Boston Consulting Group (BCG) announced the launch...

New Study Reveals AI's Transformati…

Intensive care units (ICUs) face mounting pressure to effectively manage resources while delivering optimal patient care. Groundbreaking research published in the INFORMS journal Information Systems Research highlights how a novel...